Most cited papers from Klinikum Oldenburg

Klinikum Oldenburg

What are the most cited papers from Klinikum Oldenburg?

The most cited paper from Klinikum Oldenburg is "Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer" (Rolf Sauer, Heinz Becker, Werner Hohenberger et al., 2004), with 6,117 citations. Next come "Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer" (3,899) and "ESMO consensus guidelines for the management of patients with metastatic colorectal cancer" (3,512).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 58 papers. Every paper with more than 277 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer Rolf Sauer, Heinz Becker, Werner Hohenberger et al. · New England Journal of Medicine	20 Oct 2004	6,117
2	Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer Eric Van Cutsem, Claus-Henning Köhne, Erika Hitre et al. · New England Journal of Medicine Open access	Apr 2009	3,899
3	ESMO consensus guidelines for the management of patients with metastatic colorectal cancer Eric Van Cutsem et al. · Annals of Oncology Open access	5 Jul 2016	3,512
4	DNA methylation-based classification of central nervous system tumours David Capper et al. · Nature Open access143 authors	13 Mar 2018	3,228
5	Evidence-Based Recommendations for Optimal Dietary Protein Intake in Older People: A Position Paper From the PROT-AGE Study Group Jürgen M. Bauer, Gianni Biolo, Tommy Cederholm et al. · Journal of the American Medical Directors Association Open access	16 Jul 2013	2,542
6	Preoperative Versus Postoperative Chemoradiotherapy for Locally Advanced Rectal Cancer: Results of the German CAO/ARO/AIO-94 Randomized Phase III Trial After a Median Follow-Up of 11 Years Rolf Sauer, Torsten Liersch, Susanne Merkel et al. · Journal of Clinical Oncology Open access	24 Apr 2012	2,153
7	Protein intake and exercise for optimal muscle function with aging: Recommendations from the ESPEN Expert Group Nicolaas E.P. Deutz, Jürgen Martin Bauer, Rocco Barazzoni et al. · Clinical Nutrition Open access	24 Apr 2014	1,726
8	ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making Hans‐Joachim Schmoll et al. · Annals of Oncology Open access	25 Sep 2012	1,545
9	Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group W. Hiddemann · Blood Open access	26 Aug 2005	1,327
10	Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60) Michael G. Pfreundschuh et al. · The Lancet Oncology	17 Jan 2008	1,139
11	Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation Hein Heidbüchel, Peter B. Verhamme, Marco Alings et al. · EP Europace	31 Aug 2015	1,114
12	A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma Eva Hoster, Martin H. Dreyling, Wolfram Klapper et al. · Blood	25 Oct 2007	986
13	Use of the Instantaneous Wave-free Ratio or Fractional Flow Reserve in PCI Justin E. Davies et al. · New England Journal of Medicine Open access	18 Mar 2017	982
14	Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial Gunnar Folprecht, Thomas Gruenberger, Wolf O. Bechstein et al. · The Lancet Oncology	27 Nov 2009	970
15	Entrainment of Brain Oscillations by Transcranial Alternating Current Stimulation Randolph F. Helfrich, Till R. Schneider, Stefan Rach et al. · Current Biology Open access	23 Jan 2014	895
16	European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation Hein Heidbüchel, Peter B. Verhamme, Marco Alings et al. · EP Europace Open access	26 Apr 2013	795
17	Pitfalls in the measurement of muscle mass: a need for a reference standard Fanny Buckinx et al. · Journal of Cachexia Sarcopenia and Muscle Open access	19 Jan 2018	768
18	Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial Claus Rödel et al. · The Lancet Oncology	23 May 2012	706
19	Effects of a Vitamin D and Leucine-Enriched Whey Protein Nutritional Supplement on Measures of Sarcopenia in Older Adults, the PROVIDE Study: A Randomized, Double-Blind, Placebo-Controlled Trial Jürgen Martin Bauer et al. · Journal of the American Medical Directors Association Open access	11 Jul 2015	675
20	Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates Gunnar Folprecht, Axel F. Grothey, Steven R. Alberts et al. · Annals of Oncology Open access	4 May 2005	633
21	Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95 Anja Möricke et al. · Blood Open access	19 Feb 2008	616
22	Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group Norbert Schmitz, Lorenz H. P. Trümper, Marita Ziepert et al. · Blood Open access	21 Jul 2010	605
23	Addition of cetuximab to chemotherapy as first-line treatment for KRAS wild-type metastatic colorectal cancer: Pooled analysis of the CRYSTAL and OPUS randomised clinical trials Carsten Bokemeyer, Eric Van Cutsem, Philippe Rougier et al. · European Journal of Cancer	23 Mar 2012	598
24	Towards a pan-European consensus on the treatment of patients with colorectal liver metastases Eric Van Cutsem, Bernard Nordlinger, René A. Adam et al. · European Journal of Cancer	11 Aug 2006	596
25	The addition of rituximab to a combination of fludarabine, cyclophosphamide, mitoxantrone (FCM) significantly increases the response rate and prolongs survival as compared with FCM alone in patients with relapsed and refractory follicular and mantle cell lymphomas: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group Roswitha Forstpointner · Blood	29 Jul 2004	582
26	Craniopharyngioma Hermann Lothar Muller, Thomas E. Merchant, Monika Warmuth‐Metz et al. · Nature Reviews Disease Primers Review	7 Nov 2019	534
27	EEG-Neurofeedback as a Tool to Modulate Cognition and Behavior: A Review Tutorial Stefanie Enriquez‐Geppert, Rene Jürgen Huster, Christoph Siegfried Herrmann · Frontiers in Human Neuroscience Open access	22 Feb 2017	533
28	2 years versus 1 year of adjuvant trastuzumab for HER2-positive breast cancer (HERA): an open-label, randomised controlled trial Aron Goldhirsch et al. · The Lancet	17 Jul 2013	504
29	The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML Sabine C. Käyser et al. · Blood	3 Dec 2010	491
30	Transluminal endoscopic necrosectomy after acute pancreatitis: a multicentre study with long-term follow-up (the GEPARD Study) Hans Helge Seifert, Michael Biermer, W Schmitt et al. · Gut Open access	11 Mar 2009	482
31	Treatment of colorectal cancer in older patients: International Society of Geriatric Oncology (SIOG) consensus recommendations 2013 Demetris Papamichael, Riccardo Alberto Audisio, Bengt L. G. Glimelius et al. · Annals of Oncology Open access	11 Jul 2014	475
32	Maintenance therapy with rituximab leads to a significant prolongation of response duration after salvage therapy with a combination of rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) in patients with recurring and refractory follicular and mantle cell lymphomas: results of a prospective randomized study of the German Low Grade Lymphoma Study Group (GLSG) Roswitha Forstpointner, Michael Unterhalt, Martin H. Dreyling et al. · Blood Open access	31 Aug 2006	469
33	Magnetic sensitivity of cryptochrome 4 from a migratory songbird Jingjing Xu et al. · Nature	23 Jun 2021	453
34	Creatine Deficiency in the Brain: A New, Treatable Inborn Error of Metabolism Sylvia Stöckler, Ulrike Holzbach, Folker A. Hanefeld et al. · Pediatric Research	Sep 1994	419
35	Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network Olivier Hermine et al. · The Lancet	18 Jun 2016	408
36	EHRA Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation: executive summary Hein Heidbüchel, Peter B. Verhamme, Marco Alings et al. · European Heart Journal Open access	26 Apr 2013	405
37	Differential impact of allelic ratio and insertion site in FLT3-ITD–positive AML with respect to allogeneic transplantation Richard F. Schlenk et al. · Blood Open access	Oct 2014	405
38	Cone-beam computed tomography for routine orthodontic treatment planning: A radiation dose evaluation Maria Alves Garcia Silva, Ulrich M. Wolf, Frank Heinicke et al. · American Journal of Orthodontics and Dentofacial Orthopedics	May 2008	402
39	EACTS/STS Guidelines for diagnosing and treating acute and chronic syndromes of the aortic organ Martin Czerny et al. · European Journal of Cardio-Thoracic Surgery Open access	19 Dec 2023	400
40	Improvement of Overall Survival in Advanced Stage Mantle Cell Lymphoma Annina Herrmann, Eva Hoster, Thomas Zwingers et al. · Journal of Clinical Oncology	16 Dec 2008	400
41	Endpoints in Adjuvant Treatment Trials: A Systematic Review of the Literature in Colon Cancer and Proposed Definitions for Future Trials Cornelis J. A. Punt, Marc E Buyse, C.-H. Köhne et al. · JNCI Journal of the National Cancer Institute ReviewOpen access	27 Jun 2007	382
42	Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants for the SAKK and the German CML Study Group et al. · Leukemia Open access	14 Aug 2017	342
43	Carbapenem-resistant Enterobacteriaceae in wildlife, food-producing, and companion animals: a systematic review Robin Köck, I. Daniels-Haardt, Karsten Becker et al. · Clinical Microbiology and Infection ReviewOpen access	11 Apr 2018	338
44	Selective Modulation of Interhemispheric Functional Connectivity by HD-tACS Shapes Perception Randolph F. Helfrich, Hannah Knepper, Guido Nolte et al. · PLoS Biology Open access	30 Dec 2014	335
45	The multilingual matrix test: Principles, applications, and comparison across languages: A review Birger Kollmeier, Anna Warzybok, Sabine Hochmuth et al. · International Journal of Audiology	May 2015	330
46	Application of ultrasound for muscle assessment in sarcopenia: 2020 SARCUS update Stany Perkisas et al. · European Geriatric Medicine Open access	2 Jan 2021	324
47	PEMO-Q—A New Method for Objective Audio Quality Assessment Using a Model of Auditory Perception Rainer Hüber, Birger Kollmeier · IEEE Transactions on Audio Speech and Language Processing	18 Oct 2006	319
48	Transcranial alternating current stimulation (tACS): from basic mechanisms towards first applications in psychiatry Osama Elyamany, Gregor Leicht, Christoph Siegfried Herrmann et al. · European Archives of Psychiatry and Clinical Neuroscience Open access	19 Nov 2020	316
49	Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study Jan Menne et al. · BMJ Open access	19 Jul 2012	310
50	A de novo gain-of-function mutation in SCN11A causes loss of pain perception Enrico Leipold et al. · Nature Genetics	15 Sep 2013	309

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.